Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Dermatology|April 1, 2023
Single-cell RNA sequencing analysis of a COVID-19-associated maculopapular rash in a patient with psoriasis treated with ustekinumabKatharina Rindler, Philipp Tschandl, Jasmine P Levine, et al.
Experimental Dermatology|April 2, 2015
CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skinPatrick M Brunner, Elisabeth Glitzner, Baerbel Reininger, et al.
Allergy|January 6, 2025
Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic DermatitisJonathan Bar, Ester Del Duca, Eden David, et al.
Experimental Dermatology|May 19, 2015
Bioinformatics approach for choosing the correct reference genes when studying gene expression in human keratinocytesLucian Beer, Veronika Mlitz, Maria Gschwandtner, et al.
Circulation Research|May 8, 2004
Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptorGerald W Prager, Johannes M Breuss, Stefan Steurer, et al.
The American Journal of Pathology|October 5, 2010
Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?Georg Stary, Irene Klein, Marie-Charlotte Brüggen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022
Skin microbiome and its association with host cofactors in determining atopic dermatitis severityLuise Rauer, Matthias Reiger, Madhumita Bhattacharyya, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
The role of Janus kinase signaling in the pathology of atopic dermatitisEmma Guttman-Yassky, Alan D Irvine, Patrick M Brunner, et al.
The Journal of Dermatological Treatment|June 28, 2022
Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of lifeAndrew Blauvelt, Mark Boguniewicz, Patrick M Brunner, et al.
Allergy|November 21, 2023
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergiesPeter Schmid-Grendelmeier, Melinda J Gooderham, Karin Hartmann, et al.
Pageof 9